| Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease JH Lee, D Kim, HJ Kim, CH Lee, JI Yang, W Kim, YJ Kim, JH Yoon, ... Digestive and liver disease 42 (7), 503-508, 2010 | 1516 | 2010 |
| Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis BK Koo, D Kim, SK Joo, JH Kim, MS Chang, BG Kim, KL Lee, W Kim Journal of hepatology 66 (1), 123-131, 2017 | 442 | 2017 |
| Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis FE Mózes, JA Lee, EA Selvaraj, ANA Jayaswal, M Trauner, J Boursier, ... Gut 71 (5), 1006-1019, 2022 | 434 | 2022 |
| Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials SA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ... Journal of hepatology 73 (1), 26-39, 2020 | 418 | 2020 |
| Non-alcoholic fatty liver disease across the spectrum of hypothyroidism GE Chung, D Kim, W Kim, JY Yim, MJ Park, YJ Kim, JH Yoon, HS Lee Journal of hepatology 57 (1), 150-156, 2012 | 391 | 2012 |
| Nonalcoholic fatty liver disease is associated with coronary artery calcification D Kim, SY Choi, EH Park, W Lee, JH Kang, W Kim, YJ Kim, JH Yoon, ... Hepatology 56 (2), 605-613, 2012 | 374 | 2012 |
| Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD G Lee, HJ You, JS Bajaj, SK Joo, J Yu, S Park, H Kang, JH Park, JH Kim, ... Nature communications 11 (1), 4982, 2020 | 314 | 2020 |
| KASL clinical practice guidelines: management of nonalcoholic fatty liver disease SH Kang, HW Lee, JJ Yoo, Y Cho, SU Kim, TH Lee, BK Jang, SG Kim, ... Clinical and molecular hepatology 27 (3), 363, 2021 | 230 | 2021 |
| Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial AJ Sanyal, P Lopez, EJ Lawitz, KJ Lucas, J Loeffler, W Kim, GBB Goh, ... Nature medicine 29 (2), 392-400, 2023 | 200* | 2023 |
| Body fat distribution and risk of incident and regressed nonalcoholic fatty liver disease D Kim, GE Chung, MS Kwak, HB Seo, JH Kang, W Kim, YJ Kim, JH Yoon, ... Clinical Gastroenterology and Hepatology 14 (1), 132-138. e4, 2016 | 199 | 2016 |
| Visceral adipose tissue area is an independent risk factor for hepatic steatosis BJ Park, YJ Kim, DH Kim, W Kim, YJ Jung, JH Yoon, CY Kim, YM Cho, ... Journal of gastroenterology and hepatology 23 (6), 900-907, 2008 | 199 | 2008 |
| Changing trends in etiology‐based and ethnicity‐based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States D Kim, AA Li, BJ Perumpail, C Gadiparthi, W Kim, G Cholankeril, JS Glenn, ... Hepatology 69 (3), 1064-1074, 2019 | 198 | 2019 |
| Endoplasmic reticulum stress in hepatic stellate cells promotes liver fibrosis via PERK-mediated degradation of HNRNPA1 and up-regulation of SMAD2 JH Koo, HJ Lee, W Kim, SG Kim Gastroenterology 150 (1), 181-193. e8, 2016 | 196 | 2016 |
| Roseburia spp. abundance associates with alcohol consumption in humans and its administration ameliorates alcoholic fatty liver in mice B Seo, K Jeon, S Moon, K Lee, WK Kim, H Jeong, KH Cha, MY Lim, ... Cell host & microbe 27 (1), 25-40. e6, 2020 | 190 | 2020 |
| Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis D Kim, W Kim, SK Joo, JM Bae, JH Kim, A Ahmed Clinical gastroenterology and hepatology 16 (1), 123-131. e1, 2018 | 186 | 2018 |
| Innate-like cytotoxic function of bystander-activated CD8+ T cells is associated with liver injury in acute hepatitis A J Kim, DY Chang, HW Lee, H Lee, JH Kim, PS Sung, KH Kim, SH Hong, ... Immunity 48 (1), 161-173. e5, 2018 | 185 | 2018 |
| Gene expression–based recurrence prediction of hepatitis b virus–related human hepatocellular carcinoma HG Woo, ES Park, JH Cheon, JH Kim, JS Lee, BJ Park, W Kim, SC Park, ... Clinical Cancer Research 14 (7), 2056-2064, 2008 | 181 | 2008 |
| The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans SY Choi, D Kim, HJ Kim, JH Kang, SJ Chung, MJ Park, YS Kim, CH Kim, ... Official journal of the American College of Gastroenterology| ACG 104 (8 …, 2009 | 168 | 2009 |
| Visceral obesity predicts significant fibrosis in patients with nonalcoholic fatty liver disease SJ Yu, W Kim, D Kim, JH Yoon, K Lee, JH Kim, EJ Cho, JH Lee, HY Kim, ... Medicine 94 (48), e2159, 2015 | 148 | 2015 |
| Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma W Kim, JH Yoon, JM Jeong, GJ Cheon, TS Lee, JI Yang, SC Park, HS Lee Molecular cancer therapeutics 6 (9), 2554-2562, 2007 | 142 | 2007 |
Donghee KimStanford Universityยืนยันอีเมลแล้วที่ stanford.edu